ChengDu ShengNuo Biotec Co.,Ltd. (SHA:688117)
China flag China · Delayed Price · Currency is CNY
23.15
-0.18 (-0.77%)
Jul 29, 2026, 3:00 PM CST

ChengDu ShengNuo Biotec Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
177.17157.9250.0270.3464.4861.25
Depreciation & Amortization
56.5456.5434.5627.6524.6918.26
Other Amortization
1.471.471.191.491.270.49
Loss (Gain) From Sale of Assets
---0.910.394.89
Asset Writedown & Restructuring Costs
1.531.530.59---
Loss (Gain) From Sale of Investments
-2.2-2.2-1.871.42-2.48-1.51
Provision & Write-off of Bad Debts
5.15.18.363.082.460.86
Other Operating Activities
-18.3331.820.6913.656.332.52
Change in Accounts Receivable
-79.14-79.14-49.969.82-22.22-17.6
Change in Inventory
-51.21-51.21-120.11-63.79-38.72-12.54
Change in Accounts Payable
57.3257.3283.0418.6457.6-5.28
Change in Other Net Operating Assets
2.82.84.212.851.121.11
Operating Cash Flow
147.56178.4525.2784.7895.6252.41
Operating Cash Flow Growth
571.41%606.07%-70.19%-11.34%82.44%-35.17%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-132.28-145.77-247.48-277.98-135.85-64.22
Sale of Property, Plant & Equipment
0.10.10.050.330.130.11
Divestitures
1.661.66----
Investment in Securities
-65.37-46.9213.45-93.4152.3-209.9
Other Investing Activities
-73.50.533.151.754.38-7.9
Investing Cash Flow
-269.4-190.4-230.83-369.3120.96-281.91

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-437.91302.58216.710030
Total Debt Issued
545.91437.91302.58216.710030
Long-Term Debt Repaid
--430.66-82.29-57.94-30.93-1.93
Total Debt Repaid
-449.98-430.66-82.29-57.94-30.93-1.93
Net Debt Issued (Repaid)
95.927.24220.29158.7569.0728.07
Issuance of Common Stock
--6.58--310
Common Dividends Paid
-37.62-36-34.17-29.18-26.82-0.03
Other Financing Activities
82.1589.08-0.20.18--25.85
Financing Cash Flow
140.4660.33192.51129.7542.25312.2

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-1.36-0.760.680.53-0.67
Net Cash Flow
17.2647.61-12.37-154.27161.8382.04

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
15.2832.68-222.2-193.2-40.23-11.81
Free Cash Flow Growth
------
Free Cash Flow Margin
1.91%4.41%-48.72%-44.41%-10.17%-3.06%
Free Cash Flow Per Share
0.070.15-1.01-0.87-0.18-0.06
Levered Free Cash Flow
-100.67-65.08-239.08-252.24-83.39-50.55
Unlevered Free Cash Flow
-89.22-55.62-231.71-246.57-81.36-50.45

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
5.2111.4429.957.4217.5434.69
Change in Working Capital
-73.71-73.71-88.27-33.75-1.52-34.35